# Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet

> **NCT01789606** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 1083 (actual)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** Ibuprofen 600 mg Immediate Release/Extended Release Caplet

## Key facts

- **NCT ID:** NCT01789606
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-24
- **Primary completion:** 2013-06-03
- **Final completion:** 2013-06-03
- **Target enrollment:** 1083 (ACTUAL)
- **Last updated:** 2017-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01789606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01789606, "Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT01789606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*